Over the past few years, we have seen an increasing focus on ensuring the diversity of patient populations across clinical trials.
This is hugely important, as gathering data from a diverse group ensures that results from these studies better reflect the realities of society and the patients that the industry is seeking to help.
The recent International Day of Older Persons presented a timely opportunity to consider age diversity, an often-overlooked aspect of diversity in clinical trials.
Check out the rest of this feature here
